Results 31 to 40 of about 145,467 (273)

No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke [PDF]

, 2012
Background: Dabigatran etexilate (DE) is a new oral direct thrombin inhibitor. Clinical trials point towards a favourable risk-to-benefit profile of DE compared to warfarin. In this study, we evaluated whether hemorrhagic transformation (HT) occurs after
Bohmann, Ferdinand, Förch, Christian, Lindhoff-Last, Edelgard, Mirceska, Ana, Pfeilschifter, Josef Martin (Prof. Dr.), Pfeilschifter, Waltraud, Steinmetz, Helmuth   +6 more
core   +3 more sources

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis

JAMA Neurology, 2019
Key Points Question Is dabigatran etexilate or dose-adjusted warfarin efficacious and safe to use in preventing the recurrence of venous thrombotic events among patients with cerebral venous thrombosis? Findings In this exploratory randomized, open-label
J. Ferro, J. Coutinho, F. Dentali, A. Kobayashi, A. Alasheev, P. Canhão, D. Karpov, S. Nagel, Laura Posthuma, J. Roriz, Jorge Caria, Mandy Fräßdorf, H. Huisman, P. Reilly, H. Diener   +14 more
semanticscholar   +1 more source

Drug Points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception [PDF]

, 2000
No abstract ...
Ellison, J., Greer, I.A., Thomson, A.J., Walker, I.D.   +3 more
core   +2 more sources

Warfarin Sodium Stability in Oral Formulations

Molecules, 2021
Warfarin sodium is a low-dose pharmaceutical blood thinner that exists in two forms: the clathrate form and the amorphous form. In commercially available warfarin sodium oral suspension, the active pharmaceutical ingredient (API) is added in the ...
Evangelia Dimitrokalli, Stefani Fertaki, Michail Lykouras, Petros Kokkinos, Malvina Orkoula, Christos Kontoyannis   +5 more
doaj   +1 more source

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

British medical journal, 2018
Objective To investigate the associations between direct oral anticoagulants (DOACs) and risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality compared with warfarin. Design Prospective open cohort study. Setting UK general
Y. Vinogradova, C. Coupland, T. Hill, J. Hippisley-Cox   +3 more
semanticscholar   +1 more source

One Rare Warfarin Resistance Case and Possible Mechanism Exploration

Pharmacogenomics and Personalized Medicine, 2023
Li Zhao,1 Zhenguo Zhai,2 Pengmei Li1 1Pharmacy Department, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of ...
Zhao L, Zhai Z, Li P
doaj  

Spontaneous abdominal hemorrhage due to warfarin treatment

CHRISMED Journal of Health and Research, 2016
Warfarin is an anticoagulant used in the prevention of thromboembolism. Common clinical indications for warfarin use are atrial fibrillation, artificial heart valves, deep venous thrombosis. Common side effect of warfarin is hemorrhage.
Mustafa Volkan Demir, Tuba Öztürk Demir, Selcuk Yaylaci, Ahmet Bilal Genc   +3 more
doaj   +1 more source

Large-scale structure of brown rat (Rattus norvegicus) populations in England: effects on rodenticide resistance [PDF]

, 2015
The brown rat (Rattus norvegicus) is a relatively recent (
Adams, Sally, Haniza, Mohd Z.H., Jones, Eleanor P., Lambert, Mark S., MacNicoll, Alan, Mallon, Eamonn B., Smith, Robert H.   +6 more
core   +2 more sources

Coagulation and anticoagulation in idiopathic pulmonary fibrosis [PDF]

, 2015
Idiopathic pulmonary fibrosis (IPF) is an incurable, progressive interstitial lung disease with a prognosis that is worse than that of many cancers. Epidemiological studies have demonstrated a link between IPF and thrombotic vascular events.
Crooks, Michael G., Hart, Simon P.
core   +3 more sources

Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin

Scientific Reports
Warfarin remains the most prescribed oral anticoagulant of choice in atrial fibrillation (AF) patient in resource-limited settings. Despite evidence linking Time in Therapeutic Range (TTR) to patient outcomes, its use in clinical practice is not ...
Paisit Kosum, Noppachai Siranart, Kunathip Nissaipan, Wattakorn Laohapiboolrattana, Walit Sowalertrat, Kanittha Triamamornwooth, Rawiwan Arunphan, Apiradee Sriyom, Voravut Rungpradubvong   +8 more
doaj   +1 more source